IntegraGen develops and markets molecular diagnostic tests and genomic services with research focused on autism and oncology. The company provides genotyping services and develops genetic screening and biomarker products for molecular diagnosis. It plans to commercialize a genetic autism screening test in the USA this year and advance genetic tests for colorectal and liver cancer. The €2 million financing from funds managed by A Plus Finance will be used to sustain development, accelerate R&D, and speed commercialization efforts. IntegraGen reported annual revenues of €4.6M for fiscal year 2011 and had 26 employees as of December 31, 2011. The company was founded in 2000 and is headquartered at Genopole d'Evry, with an affiliate, IntegraGen Inc., in Cambridge, MA.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2012